A first trial in the clinical application of photodynamic therapy for the prevention of restenosis after coronary-stent placement

2004 ◽  
Vol 34 (3) ◽  
pp. 235-241 ◽  
Author(s):  
Mikio Usui ◽  
Manabu Miyagi ◽  
Shinya Fukasawa ◽  
Takeshi Hara ◽  
Naoya Ueyama ◽  
...  
Keyword(s):  
Photodynamic Therapy ◽  
Clinical Application ◽  
Stent Placement ◽  
Coronary Stent

scholarly journals Attribution of Adverse Events Following Coronary Stent Placement Identified Using Administrative Claims Data

2020 ◽  
Vol 9 (4) ◽  
Author(s):  
Sanket S. Dhruva ◽  
Craig S. Parzynski ◽  
Ginger M. Gamble ◽  
Jeptha P. Curtis ◽  
Nihar R. Desai ◽  
...  
Keyword(s):  
Adverse Events ◽  
Stent Placement ◽  
Claims Data ◽  
Coronary Stent ◽  
Administrative Claims ◽  
Administrative Claims Data

Omalizumab for the Treatment of Persistent Drug Induced Urticaria Elicited by Thienopyridines: A Case Report

2020 ◽  
Vol 19 (3) ◽  
pp. 335-339 ◽  
Author(s):  
Gianfranco Calogiuri ◽  
Eustachio Nettis ◽  
Alessandro Mandurino-Mirizzi ◽  
Elisabetta Di Leo ◽  
Luigi Macchia ◽  
...  
Keyword(s):  
Case Report ◽  
Stent Placement ◽  
Coronary Stent ◽  
Drug Induced

The anti-IgE Omalizumab may be helpful to treat clopidogrel hypersensitivity without stopping thienopyridine administration in patients requirining continuous antiplatellet therapy after coronary stent placement.

Use of Prasugrel in a Patient with Clopidogrel Hypersensitivity

2011 ◽  
Vol 45 (10) ◽  
pp. 1307-1307 ◽  
Author(s):  
Sarah R Peppard ◽  
Bethanne M Held-Godgluck ◽  
Richard Beddingfield
Keyword(s):  
Percutaneous Coronary Intervention ◽  
Stent Placement ◽  
Coronary Intervention ◽  
Bare Metal Stent ◽  
Coronary Stent ◽  
Bare Metal ◽  
Metal Stent ◽  
Therapeutic Alternative ◽  
Percutaneous Coronary ◽  
Hands And Feet

Objective: To report a case of successful use of prasugrel following percutaneous coronary intervention with placement of a bare metal stent in a patient with a documented hypersensitivity reaction to clopidogrel. Case Summary: A 61-year-old male with a history of coronary artery disease with coronary stent placement presented with ST-elevation myocardial infarction. The patient had developed Stephens-Johnson syndrome 6 years earlier following Clopidogrel administration, characterized by erythematous plaques and subsequent desquamation of the hands and feet; Clopidogrel was discontinued and he was subsequently treated with ticlopidine in addition to aspirin. The third-generation thienopyridine prasugrel was initiated as a therapeutic alternative to Clopidogrel after placement of a bare metal stent; a 60-mg dose was administered after extubation, followed by 10 mg/day. No signs of allergic reaction were observed in the days, weeks, and months following administration. Discussion: Thienopyridines, specifically Clopidogrel, are the standard of care for prevention of coronary stent thrombosis; however, there are few data available on cross-hypersensitivity between these agents. One study demonstrated that 27% of patients who developed an allergic or hematologic reaction to Clopidogrel developed a similar reaction to ticlopidine. Other therapeutic options for patients with Clopidogrel hypersensitivity who are undergoing a percutaneous coronary intervention with stent placement include Clopidogrel desensitization, warfarin plus aspirin, cilostazol, ticagrelor, and ticlopidine. However, these options are limited by efficacy and/or toxicity. With its approval in 2009, prasugrel has become a potential treatment option. Conclusions: Prasugrel may be considered a therapeutic alternative in some patients allergic or intolerant to Clopidogrel, but additional data are warranted to make a strong conclusion.

scholarly journals Aspirin and clopidogrel with or without phenprocoumon after drug eluting coronary stent placement in patients on chronic oral anticoagulation

2008 ◽  
Vol 264 (5) ◽  
pp. 472-480 ◽  
Author(s):  
N. Sarafoff ◽  
G. Ndrepepa ◽  
J. Mehilli ◽  
K. Dörrler ◽  
S. Schulz ◽  
...  
Keyword(s):  
Stent Placement ◽  
Oral Anticoagulation ◽  
Coronary Stent ◽  
Drug Eluting

Effects of cilostazol treatment on angiographic restenosis after coronary stent placement

2000 ◽  
Vol 30 (12) ◽  
pp. 1494 ◽  
Author(s):  
Yun Ho Chu ◽  
Seong Wook Park ◽  
Cheol Whan Lee ◽  
Myeong Ki Hong ◽  
Jae Joong Kim ◽  
...  
Keyword(s):  
Stent Placement ◽  
Coronary Stent ◽  
Angiographic Restenosis

scholarly journals QT dispersion and prognosis after coronary stent placement in acute myocardial infarction

2007 ◽  
Vol 30 (5) ◽  
pp. 229-233 ◽  
Author(s):  
Hiroyasu Ueda, ◽  
Tomoshige Hayashi, ◽  
Kei Tsumura, ◽  
Kazuaki Kaitani, ◽  
Kiyomichi Yoshimaru, ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Acute Myocardial Infarction ◽  
Stent Placement ◽  
Qt Dispersion ◽  
Coronary Stent

scholarly journals Effect of 150-mg vs 300-mg Loading Doses of Clopidogrel on Platelet Function in Japanese Patients Undergoing Coronary Stent Placement

2008 ◽  
Vol 72 (8) ◽  
pp. 1282-1284 ◽  
Author(s):  
Kenichi Fukushima ◽  
Yoshio Kobayashi ◽  
Hideki Kitahara ◽  
Yo Iwata ◽  
Takashi Nakayama ◽  
...  
Keyword(s):  
Platelet Function ◽  
Stent Placement ◽  
Japanese Patients ◽  
Coronary Stent
Sign in / Sign up

Export Citation Format

Share Document